You can monitor any changes that take place at Lawyer you follow.
To begin to track them click on Set up Alert.
$ 95 million
Sam Duke - Editor
Pharmaceuticals and life sciences
Party: cCam Biotherapeutics (Target)
Party: Merck (Acquirer)
Party: OrbiMed (Seller, Shareholder)
Register for FREE and enjoy the following benefits:
Forgotten your password
IFLR1000's Ranking Analysis allows you to:
Subscribe today, simply call +44 (0)20 7779 8154 or email email@example.com